Sight Diagnostics’ New Device Uses Artificial Intelligence for Blood Tests

Sight Diagnostics, an Israeli digital health company that aims to bring affordable, scalable and accurate blood diagnostics to the point-of-care, has raised $27.8 million in Series C funding. The funding was led by Longliv Ventures, a division of multinational conglomerate CK Hutchison Group, who invested $10 million. Other investors included Jack Nicklaus II, Steven Esrick […]